Safety Reporting in Randomized Clinical Trials A Need for Improvement

被引：0

作者：

Yazici, Yusuf ^{[1
,2
]}

机构：

[1] New York Univ, Sch Med, Med, New York, NY USA

[2] NYU Hosp, NYU Langone Med Ctr, Dept Med, Div Rheumatol, New York, NY USA

来源：

BULLETIN OF THE HOSPITAL FOR JOINT DISEASES | 2009年 / 67卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

The reporting of adverse events (AEs) in randomized clinical trials (RCTs) is often lacking in the publication of trials. Part of the problem is the way safety data are reported in RCTs. Reporting of "time to event," use of standardized incidence ratios for comparison to normal population or disease controls, use of "patient years" when reporting AE, and adequate sample size and power calculations are some of the problems that need to be addressed and improved in RCTs.

引用

页码：209 / 210

页数：2

共 50 条

[21] Misuse and Reporting of Renal Endpoints in Randomized Clinical Trials
Halimi, Jean-Michel
AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (01) : 160 - 160
[22] The quality of reporting of randomized clinical trials published in Ophthalmology
Sánchez-Thorin, JC
Cortés, MC
Montenegro, M
Villate, N
OPHTHALMOLOGY, 2001, 108 (02) : 410 - 415
[23] Reporting the clinical importance of randomized controlled trials - Response
Man-Son-Hing, M
Chan, KBY
Molnar, FJ
Laupacis, A
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (06) : 712 - 712
[24] US FDA streamlines safety reporting in clinical trials
Reactions Weekly, 2011, 1356 (1) : 2 - 2
[25] The need for adverse effects reporting standards in oncology clinical trials
Trotti, A
Bentzen, SM
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 19 - 22
[26] Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials
Davis, Jonathan M.
Baer, Gerri R.
McCune, Susan
Klein, Agnes
Sato, Junko
Fabbri, Laura
Mangili, Alexandra
Short, Mary A.
Tansey, Susan
Mangum, Barry
Hokuto, Isamu
Nakamura, Hidefumi
Salaets, Thomas
Allegaert, Karel
Yao, Lynne
Blum, Michael
Toerner, Joseph
Turner, Mark
Portman, Ron
JOURNAL OF PEDIATRICS, 2020, 219 : 243 - +
[27] CARDIOVASCULAR SAFETY REPORTING IN BREAST CANCER CLINICAL TRIALS
Hamid, A.
Ruckdeschel, J.
Khan, M. S.
Tharwani, A.
Oshunbade, A. A.
Kipchumba, R. K.
Thigpen, C.
Anker, S. D.
Fonarow, G. C.
Hall, M. E.
Butler, J.
JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 493 - 493
[28] NEED FOR CONFIDENCE-INTERVALS IN REPORTING CLINICAL-TRIALS
HILL, ID
ALTMAN, DG
GUT, 1987, 28 (11) : 1549 - 1549
[29] Beyond CONSORT: Need for improved reporting standards for clinical trials
Meinert, CL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1487 - 1489
[30] A need for greater reporting of socioeconomic status and race in clinical trials
Lee, SJ
Kavanaugh, A
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1700 - 1701

← 1 2 3 4 5 →